The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...
Pharmacy benefit managers are the middlemen in ... Multiple current FTC commissioners have labeled the interim report and process as flawed.” ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Last year, the Federal Trade Commission (FTC) caused consternation among pharmacy benefit managers (PBMs ... highly critical report. The new document focuses on the influence of PBMs over the ...
Gloria Sachdev has spent years taking on the health-care establishment in Indiana, working to pull down high hospital prices ...